Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.27 USD | +4.96% | 0.00% | +76.39% |
Apr. 15 | Oppenheimer Cuts Veru Price Target to $5 From $7, Maintains Outperform Rating | MT |
Apr. 01 | Veru Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+76.39% | 177M | |
+89.62% | 355M | |
-4.64% | 73.73M | |
+6.23% | 66.11M |
- Stock Market
- Equities
- VERU Stock
- News Veru Inc.
- Veru : Begins Enrollment in Phase 3 Trial of Sabizabulin in Prostate Cancer